Less frequently, normocytic anemia is a complication from a particular medication. Symptoms of normocytic anemia are slow to develop and are similar to other subtypes. Many people don’t ...

Darbepoetin alfa effectively increases hemoglobin levels and reduces blood transfusion needs among chemotherapy-induced ...

A review of targeted therapies for anemia in patients with lower-risk myelodysplastic syndromes and myelofibrosis that improve transfusion independence and hemoglobin levels.

Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.However, its effects are not long-lasting as evidenced by a modest 2-year EFS rate of just 46%, prompting the need for ...

The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

“Your blood count is dangerously low,” the doctor said over the phone. “I’m sending an ambulance to take you to the hospital ...

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to ...

Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review ...

Nail changes can reveal hidden health issues long before other symptoms appear. Here's what to watch for and why it matters.

SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place ...